Search clinical trials for: Somatic BRCA mutation
Total 3723 results
-
AbbVie (prior sponsor, Abbott)CompletedPrimary Peritoneal Cancer | Fallopian Tube | Solid Tumors (e.g. Breast, Ovarian, Prostate, or Pancreatic) and OvarianNetherlands
-
Southwest Oncology GroupNational Cancer Institute (NCI)CompletedBreast Cancer | brca1 Mutation Carrier | brca2 Mutation CarrierUnited States
-
AbbVieCompletedBreast Cancer | Hepatocellular Carcinoma | Ovarian Cancer | Fallopian Tube Cancer | Metastatic Melanoma | Primary Peritoneal Cancer | Non-hematologic Malignancies
-
Rabin Medical CenterUnknownLynch Syndrome | BRCA1 Syndrome | BRCA2 SyndromeIsrael
-
The University of Texas Health Science Center at...WithdrawnOvarian Cancer | Breast Cancer Stage IV | BRCA1 Mutation | BRCA2 Mutation
-
Rabin Medical CenterUnknownBRCA1 Gene Mutation | BRCA2 Gene MutationIsrael
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)WithdrawnBreast Carcinoma | BRCA1 Mutation Carrier | BRCA2 Mutation CarrierUnited States
-
National Cancer Institute (NCI)CompletedOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cancer | Triple-Negative Breast Cancer | Serous Carcinoma CancerUnited States, Canada
-
Georgetown UniversityNational Cancer Institute (NCI)Completed
-
Georgetown UniversityNational Cancer Institute (NCI)Completed
-
Alexandru EniuIuliu Hatieganu University of Medicine and PharmacyCompletedTo Determine the Prevalence, Penetrance of BRCA1 and BRCA2 Mutations in Romanian Womens With Breast or Ovarian CancerRomania
-
Vejle HospitalAbbottCompletedRecurrent, Epithelial Ovarian CancerDenmark
-
Samsung Medical CenterAstraZenecaCompletedTo Investigate the Prevalence of BRCA 1/2 Mutation Among Ovarian Cancer
-
Cynvenio BiosystemsUnknownTriple Negative Breast Cancer | BRCA Mutation | Natural Killer CellsUnited States
-
University Hospital, ToulouseCompleted
-
Women's College HospitalCanadian Institutes of Health Research (CIHR); London Health Sciences Centre; H. Lee Moffitt Cancer Center and Research Institute and other collaboratorsUnknownBreast Cancer | Ovarian Cancer | BRCA1 Gene Mutation | BRCA2 Gene MutationCanada
-
Cancer Research UKCompletedBreast Cancer | Ovarian Cancer | brca1 Mutation Carrier | brca2 Mutation CarrierUnited Kingdom
-
Chinese Anti-Cancer AssociationUnknown
-
Health DecisionsEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedContraceptive UsageUnited States
-
Istituti Ospitalieri di CremonaUnknownBreast Cancer | Triple Negative Breast Cancer
-
Fudan UniversityUnknown
-
Memorial Sloan Kettering Cancer CenterWithdrawn
-
University of WashingtonNational Cancer Institute (NCI); National Institute of Nursing Research (NINR)CompletedDuctal Breast Carcinoma in Situ | BRCA1 Mutation Carrier | BRCA2 Mutation Carrier | Atypical Ductal Breast Hyperplasia | Lobular Breast Carcinoma in Situ | Atypical Lobular Breast HyperplasiaUnited States
-
Marie Luise Bisgaard, MDUnknownVon Hippel-Lindaus DiseaseDenmark
-
National Cancer Institute (NCI)CompletedAdult Solid Neoplasm | BRCA1 Mutation Carrier | BRCA2 Mutation CarrierUnited States
-
Vejle HospitalAbbottCompletedOvarian CancerDenmark
-
National Cancer Institute (NCI)CompletedHereditary Breast and Ovarian Cancer Syndrome | Adult Solid Neoplasm | BRCA1 Mutation Carrier | BRCA2 Mutation CarrierUnited States
-
Institut Paoli-CalmettesUnknown
-
Danish Breast Cancer Cooperative GroupUnknown
-
National Cancer Institute (NCI)TerminatedUnspecified Adult Solid Tumor, Protocol Specific | Adenocarcinoma of the Pancreas | Recurrent Pancreatic Cancer | Stage IV Pancreatic Cancer | Stage IV Breast Cancer | Stage IV Ovarian Epithelial Cancer | Stage IV Ovarian Germ Cell Tumor | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB... and other conditionsUnited States
-
Sheba Medical CenterCompletedHereditary Breast and Ovarian Cancer SyndromeIsrael
-
University College London HospitalsCompletedBreast Cancer | Hereditary Breast/Ovarian Cancer (brca1, brca2) | brca1 Mutation Carrier | brca2 Mutation CarrierAustralia, Israel, United Kingdom, Spain, Sweden, Portugal
-
University of Alabama at BirminghamNational Cancer Institute (NCI)WithdrawnOvarian Cancer | brca1 Mutation Carrier | brca2 Mutation CarrierUnited States
-
Hadassah Medical OrganizationUnknownBRCA1 Gene Mutation | BRCA2 Gene MutationIsrael
-
Catholic University of the Sacred HeartUnknownBRCA1 and BRCA2 Mutation Carrier and BRCAness PhenotypeItaly
-
Memorial Sloan Kettering Cancer CenterMemorial Health University Medical CenterCompleted
-
Dana-Farber Cancer InstituteWithdrawnOvarian Cancer | Fallopian Tube Cancer | Peritoneal CancerUnited States
-
Pomeranian Medical University SzczecinMaria Sklodowska-Curie National Research Institute of Oncology; Regional Oncology...UnknownBRCA1 Mutation | Breast Cancer Invasive NosPoland
-
Pomeranian Medical University SzczecinMaria Sklodowska-Curie National Research Institute of OncologyCompletedMetastatic Breast Cancer | BRCA1 MutationPoland
-
NYU Langone HealthWithdrawnBreast Cancer | BRCA1 Mutation | BRCA2 MutationUnited States
-
Radboud University Medical CenterUnknown
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)UnknownBreast Cancer | brca1 Mutation Carrier | brca2 Mutation CarrierUnited States
-
Hadassah Medical OrganizationUnknownBreast Cancer | Ovarian CancerIsrael
-
University of ArizonaNational Cancer Institute (NCI)CompletedOvarian Cancer | brca1 Mutation Carrier | brca2 Mutation CarrierUnited States
-
New York Presbyterian HospitalWomen At RiskUnknown
-
Women's College HospitalBioResponseUnknown
-
Memorial Sloan Kettering Cancer CenterAmerican Cancer Society, Inc.Completed
-
Baystate Medical CenterCompletedBreast CancerUnited States
-
National Taiwan University HospitalUnknown
-
Institut de Recherches Internationales ServierServier Bio-Innovation LLCNot yet recruitingMyelodysplastic Syndromes (MDS) | Hypomethylating Agent (HMA) Naive Myelodysplastic Syndromes (MDS)